Subsequently, an analysis of transcriptional sequencing data for more than 500 clinical samples in multiple public databases showed that the expression level of the CXCL3 gene in HNSCC patients, compared with normal tissues, was significantly higher, and our immunohistochemical experiments from clinical samples also confirmed this result. The gene discussed is CXCL3; the disease is head and neck squamous cell carcinoma.